Watch CNBC's full interview with Wedbush analyst Dan Ives, who explains his moves on Docusign, Rivian

Dan Ives, senior equity analyst at Wedbush Securities, joins the 'Halftime Report' to discuss why he cut his price target to $80 dollars from $200 dollars on Docusign. He also weighs in with his opinion on Rivian.